Lantronix, Inc. — Form 10-Q Summary
Reporting period: Fiscal quarter and nine months ended March 31, 2012. The request metadata labels this “2011 Q3,” but the filing covers the quarter ended March 31, 2012 (Lantronix’s fiscal third quarter). Financial amounts below are in U.S. dollars; amounts described in millions are rounded.
Business context
Lantronix designs, develops, markets and sells secure networking and device-connectivity products. Its offerings include device enablement and device management solutions for markets such as industrial automation, security, medical, retail, IT and data centers. Device enablement accounted for 78.0% of quarterly revenue.
Financial performance and liquidity
| Metric | Three months ended March 31, 2012 | Three months ended March 31, 2011 | Nine months ended March 31, 2012 | Nine months ended March 31, 2011 |
|---|---|---|---|---|
| Revenue | $12.134 million | $12.382 million | $33.770 million | $37.293 million |
| Gross profit / margin | $5.919 million / 48.8% | $6.359 million / 51.4% | $16.262 million / 48.2% | $18.864 million / 50.6% |
| Operating income (loss) | $22,000 | ($353,000) | ($2.686 million) | ($1.545 million) |
| Net income (loss) | ($41,000) | ($399,000) | ($2.862 million) | ($1.656 million) |
| Net loss per share, diluted | ($0.00) | ($0.04) | ($0.27) | ($0.16) |
- Quarterly SG&A was $4.087 million, down 17.3%; R&D was $1.775 million, up 1.3%. Nine-month SG&A fell 10.5% to $13.492 million, and R&D fell 3.0% to $5.116 million.
- Cash and cash equivalents were $1.834 million at March 31, down $4.002 million from June 30, 2011. Working capital was $2.429 million, versus $5.222 million at June 30, 2011.
- Operating cash flow was negative $2.919 million for the nine months, compared with negative $1.920 million in the prior-year period. Investing activities used $446,000 and financing activities used $637,000. Cash declined by $4.002 million.
- At March 31, debt comprised a $1.0 million term loan ($667,000 current and $333,000 long-term); there were no revolving-line borrowings. Available revolving capacity was $2.321 million, subject to borrowing-base limits. The company had $84,000 in letters of credit.
- Inventory, net, declined to $6.751 million from $9.160 million at June 30, 2011. The inventory obsolescence reserve rose to $1.822 million from $1.377 million.
Changes versus the prior comparable periods
- Quarterly revenue decreased 2.0%; nine-month revenue declined 9.4%. The nine-month decline was concentrated in device enablement, down 11.1%, and reflected lower sales of products including xPort and legacy Micro, as well as a prior-year royalty sale and $639,000 of distributor-related deferred revenue recognition that did not recur.
- Quarterly gross margin fell 2.6 percentage points. Management attributed this to higher expedited freight costs and lower manufacturing-overhead absorption. Nine-month margin fell 2.4 percentage points, primarily due to excess and obsolete inventory charges, partly offset by product mix.
- Quarterly net loss narrowed to $41,000 from $399,000, and operations returned to a small profit. For the nine-month period, however, net loss widened to $2.862 million from $1.656 million.
- The quarter’s lower SG&A reflected reduced professional fees following completion of an internal investigation, cost reductions, lower share-based compensation and travel costs. A November 2011 restructuring reduced the workforce by 14 employees and generated $286,000 of charges through March 31.
Outlook, risks and unusual items
- Management said available cash, operating cash generation, the recent equity proceeds and, if needed, credit availability were expected to fund working capital, capital expenditures and other commitments for at least the next 12 months. It also cautioned that profitability and positive cash flow were not assured and that additional financing might be needed, potentially on unacceptable or dilutive terms.
- After quarter-end, Lantronix sold 1,605,709 shares to its largest shareholder, TL Investment GmbH, for approximately $4.4 million net proceeds. The related-party investor is beneficially owned by a company founder and director.
- On May 1, 2012, the company completed a public offering of 2.2 million shares for approximately $4.9 million in net proceeds, excluding any over-allotment. Combined net proceeds from the two transactions were approximately $9.3 million. The underwriter had a 30-day option for up to 330,000 additional shares.
- The company had previously failed its minimum tangible net worth covenant in May and June 2011; the lender waived and amended the covenant. Lantronix was compliant at March 31, 2012, with tangible net worth of $2.884 million against a $2.5 million minimum. Management warned that continued losses could impair future compliance. Substantially all assets are pledged to Silicon Valley Bank.
- Key stated risks include recurring losses and cash use, possible need for additional capital, dilution from share issuance, credit-facility restrictions and covenant compliance, global economic weakness and international-market exposure, and the risk that products fail to keep pace with technology, standards or competitors. Management identified no material legal proceedings; the filing reported no off-balance-sheet arrangements.
- Management estimated the reporting unit’s fair value at $29.6 million at March 31, compared with a carrying amount of $12.4 million, including $9.5 million of goodwill; impairment could arise if actual results or valuation assumptions deteriorate.
Important facts for investors to verify
- Whether the recent equity proceeds materially improve cash runway, and the effect of the offerings on shares outstanding, ownership and dilution.
- Whether Lantronix can generate sustained positive operating cash flow and profitability, given nine-month losses and cash used in operations.
- Whether sales stabilize and new products offset weaker legacy-product demand; monitor revenue by product line and region.
- Whether gross margins recover and inventory reserves, freight costs and manufacturing absorption remain under control.
- Whether the company maintains compliance with its amended SVB covenant and retains access to the borrowing base under the credit agreement.
- Whether the 14-employee restructuring delivers ongoing expense savings without impairing product development or sales execution.